Hepatocellular carcinoma with carcinoid features.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 6147306)

Published in Hum Pathol on September 01, 1984

Authors

S H Barsky, I Linnoila, T J Triche, J Costa

Articles by these authors

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A (1992) 5.94

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst (2001) 5.09

The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med (1994) 4.65

Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63

Tumor invasion and the extracellular matrix. Lab Invest (1983) 3.81

PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res (1996) 3.74

The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg (1982) 3.65

Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol (1997) 3.60

Tissue microarray: a new technology for amplification of tissue resources. Cancer J (2001) 3.19

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet (1994) 3.17

Isolation of a tumor cell laminin receptor. Biochem Biophys Res Commun (1983) 3.05

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet (1989) 2.94

A database of vertebrate longevity records and their relation to other life-history traits. J Evol Biol (2009) 2.93

Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J (1993) 2.91

Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest (1997) 2.28

Chromosome translocation in peripheral neuroepithelioma. N Engl J Med (1984) 2.22

Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol (1996) 2.20

Human immune response to sand fly salivary gland antigens: a useful epidemiological marker? Am J Trop Med Hyg (2000) 2.18

Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms. Arch Pathol Lab Med (1994) 2.18

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12

The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res (1997) 2.08

Clinicians are from Mars and pathologists are from Venus. Arch Pathol Lab Med (2000) 2.05

Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet (1986) 2.04

The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol (1980) 2.00

Extraskeletal Ewing's sarcoma: results of combined modality treatment. J Clin Oncol (1983) 1.99

The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer (1984) 1.93

Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2003) 1.91

Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest (1983) 1.91

Breast-cancer diagnosis with nipple fluid bFGF. Lancet (2000) 1.86

Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med (1998) 1.86

Neuroblastoma and the differential diagnosis of small-, round-, blue-cell tumors. Hum Pathol (1983) 1.85

Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med (1982) 1.83

Retinoblastoma--origin from a primitive neuroectodermal cell? Nature (1984) 1.78

Dynamic model of differentiation in Ewing's sarcoma cells. Comparative analysis of morphologic, immunocytochemical, and oncogene expression parameters. Lab Invest (1992) 1.75

Mucinous cystadenoma of the lung. A report of two cases with immunohistochemical and ultrastructural analysis. Arch Pathol Lab Med (1990) 1.71

Experimental evidence for a neural origin of Ewing's sarcoma of bone. Am J Pathol (1987) 1.68

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med (1982) 1.67

An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res (2001) 1.65

Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med (1998) 1.63

[Health inequalities in Barcelona and Valencia]. Med Clin (Barc) (1993) 1.61

A novel human xenograft model of inflammatory breast cancer. Cancer Res (1999) 1.61

Human breast carcinoma desmoplasia is PDGF initiated. Oncogene (2000) 1.59

Increased content of Type V Collagen in desmoplasia of human breast carcinoma. Am J Pathol (1982) 1.59

Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57

Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer (1992) 1.56

Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma. Ann Surg (1977) 1.55

Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis. Hum Pathol (1998) 1.54

Combined small-cell and transitional cell carcinoma of the renal pelvis. A light microscopic, immunohistochemical, and ultrastructural study of a case with literature review. Arch Pathol Lab Med (1993) 1.53

The EWS/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene (2007) 1.53

The myoepithelial defense: a host defense against cancer. Med Hypotheses (1997) 1.53

Immunoglobulin binding to herpes virus-induced Fc receptors inhibits virus growth. Nature (1977) 1.50

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol (1987) 1.50

Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. Clin Pharmacokinet (1995) 1.49

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ (1999) 1.46

Factors influencing chelator-stable, detergent-extractable, phorbol diester-induced membrane association of protein kinase C. Differences between Ca2+-induced and phorbol ester-stabilized membrane bindings of protein kinase C. J Biol Chem (1986) 1.45

Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res (2001) 1.44

Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology (1993) 1.44

Laminin molecular domains which alter metastasis in a murine model. J Clin Invest (1984) 1.43

Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol (1999) 1.43

Expression profiling of human tumors: the end of surgical pathology? J Mol Diagn (2001) 1.43

Intravascular papillary endothelial hyperplasia: a neoplastic "actor" representing an exaggerated attempt at recanalization mediated by basic fibroblast growth factor. J Hand Surg Am (1994) 1.41

Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection. J Viral Hepat (2006) 1.40

Port wine stains and the response to argon laser therapy: successful treatment and the predictive role of color, age, and biopsy. Plast Reconstr Surg (1980) 1.39

An efficient locally affine framework for the smooth registration of anatomical structures. Med Image Anal (2008) 1.38

Characteristics of the Fc receptor induced by herpes simplex virus. Intervirology (1978) 1.38

Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol Cell Biol (2001) 1.38

Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse. Proc Natl Acad Sci U S A (1994) 1.36

ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene (2010) 1.35

An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol (1990) 1.35

Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res (1995) 1.33

Monoclonal antibodies to the human laminin receptor recognize structurally distinct sites. Exp Cell Res (1985) 1.32

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet (1982) 1.31

Interferon inhibits mouse leukaemia virus release: an electron microscope study. J Gen Virol (1977) 1.31

Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery (1985) 1.30

Gastric dysplasia. A histological follow-up study. Am J Surg Pathol (1987) 1.28

Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med (1983) 1.27

Efficacy and safety of two new methods of rapid intravenous detoxification in heroin addicts previously treated without success. Br J Psychiatry (1997) 1.27

Properties of the cell surface Fc-receptor induced by herpes simplex virus. J Immunol (1978) 1.26

Treatment of peripheral neuroepithelioma in children and young adults. J Clin Oncol (1987) 1.24

Idiopathic entero-colic lymphocytic phlebitis. A cause of ischemic intestinal necrosis. Am J Surg Pathol (1989) 1.23

Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas. Surgery (1978) 1.23

Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis (2006) 1.23

Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. Cancer Lett (2000) 1.23

K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol (1994) 1.23

Presence of human papilloma viral antigens in juvenile multiple laryngeal papilloma. Am J Clin Pathol (1981) 1.22

Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A (1982) 1.21

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol (1997) 1.19

Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res (1992) 1.19

Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients. Clin Rheumatol (2009) 1.19

Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res (1988) 1.18

Crystal structure of plant aspartic proteinase prophytepsin: inactivation and vacuolar targeting. EMBO J (1999) 1.18

High-grade soft tissue sarcomas of the extremities. Cancer (1986) 1.18

Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol (1983) 1.17

Neuron-specific enolase in the diagnosis of neuroblastoma and other small, round-cell tumors in children. Hum Pathol (1984) 1.17

The fate of IgE bound to rat basophilic leukemia cells. J Immunol (1979) 1.16

Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. Blood (1985) 1.16

The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res (1998) 1.15

Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest (1987) 1.15